NCT00328016

Brief Summary

The purpose of this study is to investigate the nature of the physiological reasons for the decreases in resting blood pressure that can result from systematic practice of computer-guided breathing exercises or meditative relaxation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2006

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2006

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

May 18, 2006

Completed
1 day until next milestone

First Posted

Study publicly available on registry

May 19, 2006

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2009

Completed
7.6 years until next milestone

Results Posted

Study results publicly available

July 2, 2017

Completed
Last Updated

July 2, 2017

Status Verified

December 1, 2016

Enrollment Period

3.7 years

First QC Date

May 18, 2006

Results QC Date

April 30, 2013

Last Update Submit

June 5, 2017

Conditions

Keywords

hypertensionhigh blood pressuremeditation

Outcome Measures

Primary Outcomes (1)

  • Breathing Rate

    Breathing rate was monitored continuously via inductive plethysmography.

    After 15 minutes of guided breathing or control task

Secondary Outcomes (2)

  • Minute Ventilation

    After 15 minutes of guided breathing or control task

  • End Tidal CO2 (PetCO2)

    After 15 minutes of guided breathing or control task

Study Arms (2)

Device Guided Breathing

EXPERIMENTAL

Individual breathing rate was determined from an expandable band around the torso connected to a commercially available device (RESPeRATE, Lod, Israel) that presented distinctive tones via earphones.

Device: RESPeRATE

Control Group

PLACEBO COMPARATOR

Control group were instructed to sit in the same manner passively attend to their breathing, and silently repeat 'one' during each exhalation. If other thoughts came to mind, they were instructed to calmly attend to their breathing.

Behavioral: Guided Breathing

Interventions

The participant will engage in daily 15 min sessions of meditative relaxation that involves quiet attention to breathing pattern with no attempt to manipulate breathing pattern

Control Group
RESPeRATEDEVICE

The participant will be trained to perform a guided breathing task that involves a chest expansion sensor, battery-powered microcomputer, and earphones

Device Guided Breathing

Eligibility Criteria

Age40 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Over 21 years
  • Systolic blood pressure 130-160 or diastolic blood pressure 85-100

You may not qualify if:

  • More than one antihypertensive medication
  • Beta blockers, angiotensin converting enzyme inhibitors or angiotensin receptor blockers
  • History of coronary artery disease, heart failure, stroke, angina or coronary revascularization
  • Kidney disease, defined as plasma creatinine \> 1.5mg/dL
  • Diabetes, defined by insulin or oral hypoglycemic medication or blood sugar \> 126mg/dL
  • Pulmonary disease, defined as chronic obstructive pulmonary disease, bronchitis, asthma, or use of inhaler
  • Upper respiratory infection during past 30 days
  • Medication that affects central nervous system function
  • Steroid use
  • Current pregnancy or lactation within past six months
  • Current birth control medication or hormone replacement therapy
  • Condition that in the judgment of the Principal Investigator is incompatible with the research study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

NIA Clinical Research Unit

Baltimore, Maryland, 21225, United States

Location

Related Publications (6)

  • Meles E, Giannattasio C, Failla M, Gentile G, Capra A, Mancia G. Nonpharmacologic treatment of hypertension by respiratory exercise in the home setting. Am J Hypertens. 2004 Apr;17(4):370-4. doi: 10.1016/j.amjhyper.2003.12.009.

    PMID: 15062893BACKGROUND
  • Elliot WJ, Izzo JL Jr, White WB, Rosing DR, Snyder CS, Alter A, Gavish B, Black HR. Graded blood pressure reduction in hypertensive outpatients associated with use of a device to assist with slow breathing. J Clin Hypertens (Greenwich). 2004 Oct;6(10):553-9; quiz 560-1. doi: 10.1111/j.1524-6175.2004.03553.x.

    PMID: 15470284BACKGROUND
  • Grossman E, Grossman A, Schein MH, Zimlichman R, Gavish B. Breathing-control lowers blood pressure. J Hum Hypertens. 2001 Apr;15(4):263-9. doi: 10.1038/sj.jhh.1001147.

    PMID: 11319675BACKGROUND
  • Benson H. The Relaxation Response. New York: Avon Books, 1975

    BACKGROUND
  • Anderson DE, McNeely JD, Chesney MA, Windham BG. Breathing variability at rest is positively associated with 24-h blood pressure level. Am J Hypertens. 2008 Dec;21(12):1324-9. doi: 10.1038/ajh.2008.292. Epub 2008 Sep 25.

  • Anderson DE, McNeely JD, Windham BG. Regular slow-breathing exercise effects on blood pressure and breathing patterns at rest. J Hum Hypertens. 2010 Dec;24(12):807-13. doi: 10.1038/jhh.2010.18. Epub 2010 Mar 4.

MeSH Terms

Conditions

Hypertension

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Results Point of Contact

Title
Jessica McNeeley, Research Fellow
Organization
National Institute on Aging

Study Officials

  • William B. Ershler, M.D.

    NIA, Clinical research Unit

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
NIH
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 18, 2006

First Posted

May 19, 2006

Study Start

April 1, 2006

Primary Completion

December 1, 2009

Study Completion

December 1, 2009

Last Updated

July 2, 2017

Results First Posted

July 2, 2017

Record last verified: 2016-12

Data Sharing

IPD Sharing
Will not share

There is no plan to share individual level data.

Locations